-
Ravindra fit for New Zealand ODI series against India
-
Kenyan great Kipchoge wins first marathon in three years
-
All Blacks lose four players for second Wallabies Test
-
Barca extend perfect streak, Real Madrid survive Vinicius red
-
Spanish women return to action with 2-0 friendly win over USA
-
PSG ease to Ligue 1 win before Manchester City test
-
Bordeaux-Begles end wait for away win before Champions Cup defence
-
Real Madrid edge Villarreal, Vinicius sent off for hair pull
-
Traumatized Panamanians begin quake recovery
-
Carrick demands more 'streetwise' Man Utd after Spurs setback
-
Palestinian Mahmoud Abu Hamda wins top photography prize at Bayeux
-
10-man Tottenham ramp up pressure on Man Utd boss Carrick
-
Inter Milan dominate Parma to go top of Serie A
-
India 'cockroach' movement says thousands detained in Delhi protest
-
Barca extend perfect streak, Atletico scrape late win
-
Injury ends season for NHL Rangers star goalie Shesterkin
-
10-man Tottenham strike back to hold Man Utd
-
Ten-man Spurs rescue draw at Man Utd, Arsenal survive Leeds scare
-
Gordon nets first Barca goal as Liga leaders beat Getafe
-
Inter Milan dominate Parma to go top in Serie A
-
Trump, Zelensky clash over diesel deal as Russian strikes kill 21
-
Abbas postpones Palestinian legislative elections to September 2027
-
Thousands join pro-Palestinian marches in several European cities
-
'I don't feel fear': Fulham boss Arbeloa hits back as pressure mounts
-
Sleightholme scores hat-trick as Northampton overwhelm Bath in 18-try clash
-
Hurricane Simon strengthens to category 4 as it nears western Mexico
-
US lethal injection survivor returns to prison
-
Alonso hails Henderson 'beauties' as Chelsea star rolls back the years
-
누샤 아우벨: 연 기본급 143,056유로 — 포츠담 시민은 돈줄 취급을 받으며 부담을 떠안아야 한다
-
Noosha Aubel: roční základní plat 143 056 eur — a obyvatelé Postupimi mají sloužit jako dojné krávy
-
Renshaw ends long wait to put Australia on top in first S.Africa Test
-
Romero claims Atletico late win at Alaves
-
ヌーシャ・アウベル:年間基本給143,056ユーロ――ポツダム市民は金づるとして負担を強いられる
-
Zelensky blasts diesel deal as Russian strikes kill 16
-
Noosha Aubel: 143 056 euro rocznego wynagrodzenia zasadniczego - a mieszkańcy Poczdamu mają służyć za dojne krowy
-
Arsenal back on track after Leeds scare, five-star Chelsea run riot
-
努莎・奧貝爾:年基本薪資143,056歐元——波茨坦市民卻得充當搖錢樹埋單
-
Bayern draw at Augsburg despite conceding fastest-ever Bundesliga goal
-
Verstappen on pole as he hunts first Singapore Grand Prix win
-
French prodigy Seixas becomes youngest Giro di Lombardia winner
-
Isaias drenches southern US as weakened post-tropical cyclone
-
Verstappen on pole position as he hunts first Singapore GP win
-
Australia strike early after Renshaw's 190 against South Africa
-
Arsenal learned lessons from Brighton collapse, says Arteta
-
India 'cockroach' movement says thousands detained during major protest in capital
-
Noosha Aubel: €143,056 in annual basic pay — while Potsdam’s residents are expected to serve as cash cows
-
Nobel peace laureate Pillay calls US sanctions on ICC 'unacceptable'
-
Cristiano Ronaldo provisionally suspended by Portugal after walkout
-
Roma goalkeeper Svilar sidelined for a month with broken finger
-
Brilliant Renshaw ton puts Australia in strong position
Texas judge to decide fate of abortion pill in US
A conservative Texas judge is poised to rule on whether to impose a nationwide ban on a drug used for more than half of the abortions in the United States.
Mifepristone, also known as RU-486, is one component of a two-drug regimen used for medication abortion and has been on the US market for more than 20 years.
Anti-abortion groups, galvanized by the Supreme Court's ruling in June overturning the constitutional right to an abortion, have now set their sights on obtaining a ban on the abortion pill.
In a lawsuit filed in November with a Texas judge appointed by former Republican president Donald Trump, an alliance of anti-abortion groups claims the US Food and Drug Administration (FDA) should never have approved the "dangerous" drug.
"The FDA failed America's women and girls when it chose politics over science and approved chemical abortion drugs for use in the United States," they said.
Attorneys for the Alliance Defending Freedom, a Christian legal advocacy group, asked the judge to impose an immediate injunction withdrawing mifepristone from the list of FDA-approved drugs.
The FDA urged the judge to reject the request.
"The public interest would be dramatically harmed by effectively withdrawing from the marketplace a safe and effective drug that has lawfully been on the market for 22 years," it said.
US District Court Judge Matthew Kacsmaryk has given the parties until February 24 to file briefs in the case and is expected to rule sometime after that.
Around 15 US states have imposed restrictions on abortion since the Supreme Court ruling and banned sales of the abortion pill.
Groups defending access to abortion have expressed concern that Kacsmaryk, who previously worked for the conservative First Liberty Institute, could impose a nationwide ban on its sale.
"Access to medication abortion would end across the country -- even in those states where abortion rights are protected," the Center for Reproductive Rights said.
The American Civil Liberties Union said if the suit is successful, it could "force millions of Americans seeking abortions to undergo operations (and) carry unwanted pregnancies to term."
Mifepristone is used in combination with another drug called misoprostol and is approved for use in the United States up to 10 weeks of pregnancy.
Medication abortions account for 54 percent of all abortions in the United States, according to the Guttmacher Institute, a reproductive health policy and research group.
J.AbuHassan--SF-PST